Thyroid Eye Disease

DBCOND0051704Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Thyroid Eye Disease is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Graves Ophthalmopathy · Endocrine ophthalmopathy · Thyroid Associated Ophthalmopathy · Graves' Ophthalmopathy · Thyroid-Associated Ophthalmopathy
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0009625SNOMED CT148010005MedDRA10014702UMLSC0155264

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
143Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Thyroid Eye Disease share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In